FDA Inspection
Xttrium Laboratories, Inc.Xttrium Laboratories, Inc. – FDA Inspection, Jun 16, 2026
Record Details
This FDA Inspection record concerns Xttrium Laboratories, Inc., with an inspection on June 16, 2026, issued by the Chicago District Office, covering human drugs.
View Company Profile
ID · 880e83dd-361d-4801-8f26-2e2c1bffe6a9
Inspection Facts
- Inspection number
- 1324176
- FDA center
- Human Drugs
Other FDA inspections of Xttrium Laboratories, Inc.
15| Date | Classification | Office | Project area |
|---|---|---|---|
| June 18, 2025 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 8, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 6, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 15, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 11, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Xttrium Laboratories, Inc.
- FDA Inspection 1273417 - 2025-06-18
- FDA Inspection 1234354 - 2024-03-08
- FDA Inspection 1230448 - 2024-02-06
- FDA Inspection 1046665 - 2018-03-15
- FDA Inspection 977965 - 2016-07-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.